Insider trade

Jack Anders, CFO at Revolution Medicines, sold ~$73K of Revolution Medicines shares.

~$73K
Approx. value · 1,864 sh @ $39.04
115K
Holds after · shares reported
Traded
Mar 17, 2025
Filed
Mar 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 21, 2025InsiderOfficer sold ~$97K of RVMD shares in the open market
  2. Mar 17, 2025 · this disclosureInsiderCFO sold ~$73K of RVMD shares in the open market

What came next

  1. Mar 17, 2025Insider · 4 peopleInsiders: 4 sales (~$763K)
  2. Mar 20, 2025InsiderOfficer sold ~$79K of RVMD shares in the open market
  3. Jun 16, 2025Insider · 6 peopleInsiders: 6 sales (~$1.1M)
  4. Jun 20, 2025InsiderOfficer sold ~$76K of RVMD shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Revolution Medicines

For Revolution Medicines, OQRO holds 13 insider filings (SEC Form 4 or Form 144), 20 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RVMD page.

Other recent filings by Jack Anders, Chief Financial Officer

The full history of Jack Anders, Chief Financial Officer is on the profile page.

How this filing works

Other disclosures at Revolution Medicines

Everything OQRO holds on this company is on its RVMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data